Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a new turkish questionnaire capture the hidden impact of facial palsy?

NCT ID NCT07750561

Knowledge-focused Sponsor: Barış CELBEK Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This study aims to translate and adapt the Synkinesis Assessment Questionnaire (SAQ) into Turkish and check if it is a reliable and valid tool for people with peripheral facial palsy. Synkinesis causes involuntary facial movements during voluntary expressions, affecting appearance and quality of life. About 49 Turkish-speaking adults with facial palsy and synkinesis will complete the Turkish SAQ and a related questionnaire to test its accuracy and consistency.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Synkinesis Assessment Questionnaire (SAQ) - a patient-reported outcome measure
What this could lead to
If successful, this could provide a reliable Turkish tool to measure synkinesis severity, improving clinical care and research for Turkish-speaking patients.
What could go wrong
This is a small, single-center study focused on questionnaire validation, not treatment. The results may not generalize to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 49 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of Turkish-speaking adults (≥18 years) with clinically confirmed synkinesis secondary to peripheral facial palsy for at least 6 months. Participants will be recruited from outpatient clinics and will undergo assessment using the Turkish version of the Synkinesis Assessment Questionnaire (SAQ), the Facial Disability Index (FDI), and the Sunnybrook Facial Grading System (SFGS) as part of the psychometric evaluation of the Turkish SAQ.

Ages

Up to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older. * Diagnosis of peripheral facial palsy. * At least 6 months since the onset of peripheral facial palsy. * Clinically confirmed facial synkinesis. * Ability to read, write, and speak Turkish. * Provision of written informed consent to participate in the study. Exclusion Criteria: * Presence of a secondary neurological disorder that may affect the facial muscles, such as Parkinson's disease or multiple sclerosis. * Cognitive impairment or severe psychiatric illness that may prevent understanding or completion of the questionnaires. * History of congenital facial palsy. * History of major facial surgery or trauma that may affect the assessment of synkinesis. * Planned botulinum toxin injection or surgical intervention during the test-retest assessment period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bell palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Bell's palsy facial paralysis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bell palsy Facial palsy Facial paralysis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Biruni University

    Istanbul, Cevizlibağ, 34015, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.